共 50 条
Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
被引:8
作者:
Kang, Yu Mi
[1
]
Jung, Chang Hee
[1
]
Cho, Yun Kyung
[1
]
Lee, Seung Eun
[1
]
Lee, Min Jung
[2
]
Hwang, Jenie Yoonoo
[2
]
Kim, Eun Hee
[2
]
Park, Joong-Yeol
[1
]
Lee, Woo Je
[1
]
Kim, Hong-Kyu
[2
]
机构:
[1] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Hlth Screening & Promot Ctr, Asan Med Ctr, Seoul, South Korea
来源:
PLOS ONE
|
2017年
/
12卷
/
04期
关键词:
CARDIOVASCULAR-DISEASE;
ALL-CAUSE;
RISK;
ASSOCIATION;
CALCIUM;
ATHEROSCLEROSIS;
FRAMINGHAM;
MORTALITY;
DEFINITION;
PREDICTION;
D O I:
10.1371/journal.pone.0175762
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Objectives Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. Methods We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by >= 2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. Results Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93-2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34-4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71-2.24). Conclusions Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status.
引用
收藏
页数:13
相关论文